Nebulized Beclomethasone Dipropionate Improves Respiratory Lung Function in Preschool Children With Recurrent Wheezing
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
This is a single-centre, open label study, aiming to evaluate the efficacy of beclomethasone
dipropionate applied for 12 weeks with a dose of 400 µg twice a day (total dose 800 µg
nebulized), on airway resistance and reactances (measured with Rint and FOT techniques) in
children with recurrent wheezing, aged 2-5 years. In addition, clinic score as frequency of
symptoms and exacerbations, will be assessed.
Phase:
Phase 4
Details
Lead Sponsor:
Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy Istituto per la Ricerca e l'Innovazione Biomedica